002030 达安基因
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-1.812-11.0401.03758.03462.275
总资产报酬率 ROA (%)-1.516-8.9840.81243.13742.476
投入资产回报率 ROIC (%)-1.739-10.4920.99154.96755.868

边际利润分析
销售毛利率 (%)32.66737.54750.46772.84274.765
营业利润率 (%)-32.850-125.15510.29952.54253.826
息税前利润/营业总收入 (%)-39.559-133.2003.28551.53453.355
净利润/营业总收入 (%)-29.945-110.0926.07445.05647.212

收益指标分析
经营活动净收益/利润总额(%)128.04919.14241.799108.47898.636
价值变动净收益/利润总额(%)-118.86640.104360.6295.5943.285
营业外收支净额/利润总额(%)2.4610.332-7.122-0.163-0.129

偿债能力分析
流动比率 (X)3.0592.9233.0852.9542.374
速动比率 (X)2.8522.7702.9462.8292.178
资产负债率 (%)12.08814.97216.88921.28625.894
带息债务/全部投入资本 (%)1.8172.4884.1502.0725.893
股东权益/带息债务 (%)5,295.3463,850.3552,273.6244,656.1781,563.747
股东权益/负债合计 (%)704.168549.549477.214359.775274.665
利息保障倍数 (X)6.72717.462-0.519-55.909-132.714

营运能力分析
应收账款周转天数 (天)555.223698.914933.39894.51888.190
存货周转天数 (天)156.212147.901187.44447.49975.332